Nano-sized calcium phosphate particles for periodontal gene therapy

Journal of Periodontology

Volumn 84, Issue 1, 2013, Pages 117-125

  Elangovan, Satheesh ^a   Jain, Shardool ^b   Tsai, Pei Chin ^b   Margolis, Henry C ^c   Amiji, Mansoor ^b  

^a UNIVERSITY OF IOWA   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c FORSYTH INSTITUTE   (United States)

Author keywords

Biocompatible materials; Gene therapy; Guided tissue regeneration

Indexed keywords

3 (4,5 DIMETHYLTHIAZOL 2 YL) 5 (3 CARBOXYMETHOXYPHENYL) 2 (4 SULFOPHENYL) 2H TETRAZOLIUM; 3-(4,5-DIMETHYLTHIAZOL-2-YL)-5-(3-CARBOXYMETHOXYPHENYL)-2-(4-SULFOPHENYL)-2H-TETRAZOLIUM; BIOMATERIAL; CALCIUM PHOSPHATE; DIAGNOSTIC AGENT; GREEN FLUORESCENT PROTEIN; LUMINESCENT AGENT; NANOPARTICLE; PLATELET DERIVED GROWTH FACTOR B; TETRAZOLIUM; THIAZOLE DERIVATIVE;

ANIMAL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METHODOLOGY; MOUSE; PERIODONTAL DISEASE; PLASMID; SYNTHESIS;

ANIMALS; BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LUMINESCENT AGENTS; MICE; NANOPARTICLES; NIH 3T3 CELLS; PERIODONTAL DISEASES; PLASMIDS; PROTO-ONCOGENE PROTEINS C-SIS; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION;

EID: 84872006902     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.120012     Document Type: Article

References (38)

1. Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest 1988; 81:277-281.
2. Lynch SE, Colvin RB, Antoniades HN. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 1989;84: 640-646.
3. Elangovan S, Srinivasan S, Ayilavarapu S. Novel regenerative strategies to enhance periodontal therapy outcome. Expert Opin Biol Ther 2009;9:399-410.
4. Hollinger JO, Hart CE, Hirsch SN, Lynch S, Friedlaender GE. Recombinant human platelet-derived growth factor: Biology and clinical applications. J Bone Joint Surg Am 2008;90(Suppl. 1):48-54.
5. Javed F, Al-Askar M, Al-Rasheed A, Al-Hezaimi K. Significance of the platelet-derived growth factor in periodontal tissue regeneration. Arch Oral Biol 2011; 56:1476-1484.
6. Winn SR, Hu Y, Sfeir C, Hollinger JO. Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev 2000;42:121-138.
7. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003;88: 873-884.
8. Elangovan S, Karimbux N. Review paper: DNAdelivery strategies to promote periodontal regeneration. J Biomater Appl 2010;25:3-18.
9. Ramseier CA, Abramson ZR, Jin Q, Giannobile WV. Gene therapeutics for periodontal regenerative medicine. Dent Clin North Am 2006;50:245-263, ix.
10. Cotrim AP, Baum BJ. Gene therapy: Some history, applications, problems, and prospects. Toxicol Pathol 2008;36:97-103.
11. Zhu Z, Lee CS, Tejeda KM, Giannobile WV. Gene transfer and expression of platelet-derived growth factors modulate periodontal cellular activity. J Dent Res 2001;80:892-897.
12. Giannobile WV, Lee CS, Tomala MP, Tejeda KM, Zhu Z. Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering. J Periodontol 2001;72:815-823.
13. Anusaksathien O, Webb SA, Jin QM, Giannobile WV. Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair. Tissue Eng 2003;9:745- 756.
14. JinQ,Anusaksathien O, Webb SA, PrintzMA,Giannobile WV. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 2004;9: 519-526.
15. Dunn CA, Jin Q, Taba M Jr., Franceschi RT, Bruce Rutherford R, Giannobile WV. BMP gene delivery for alveolar bone engineering at dental implant defects. Mol Ther 2005;11:294-299.
16. Chang PC, Seol YJ, Cirelli JA, et al. PDGF-B gene therapy accelerates bone engineering and oral implant osseointegration. Gene Ther 2010;17:95-104.
17. Gu DL, Nguyen T, Gonzalez AM, et al. Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. Mol Ther 2004;9:699-711.
18. Chang PC, Cirelli JA, Jin Q, et al. Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use. Hum Gene Ther 2009;20:486-496.
19. Yang Y, Nunes FA, Berencsi K, Furth EE, Gönczöl E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 1994;91:4407-4411.
20. Thaci B, Ulasov IV, Wainwright DA, Lesniak MS. The challenge for gene therapy: Innate immune response to adenoviruses. Oncotarget 2011;2:113-121.
21. Ragusa A, García I, Penadés S. Nanoparticles as nonviral gene delivery vectors. IEEE Trans Nanobioscience 2007;6:319-330.
22. Oligino TJ, Yao Q, Ghivizzani SC, Robbins P. Vector systems for gene transfer to joints. Clin Orthop Relat Res 2000;379(Suppl.):S17-S30.
23. Zhang Y, Wang Y, Shi B, Cheng X. A platelet-derived growth factor releasing chitosan/coral composite scaffold for periodontal tissue engineering. Biomaterials 2007;28:1515-1522.
24. Peng L, Cheng X, Zhuo R, et al. Novel gene-activated matrix with embedded chitosan/plasmid DNA nanoparticles encoding PDGF for periodontal tissue engineering. J Biomed Mater Res A 2009;90:564- 576.
25. LeGeros RZ. Calcium phosphate materials in restorative dentistry: A review. Adv Dent Res 1988;2:164- 180.
26. LeGeros RZ. Calcium phosphate-based osteoinductive materials. Chem Rev 2008;108:4742-4753.
27. Orrantia E, Chang PL. Intracellular distribution of DNA internalized through calcium phosphate precipitation. Exp Cell Res 1990;190:170-174.
28. Olton D, Li J, Wilson ME, et al. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: Influence of the synthesis parameters on transfection efficiency. Biomaterials 2007;28:1267-1279.
29. van der Woude I, Wagenaar A, Meekel AA, et al. Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery. Proc Natl Acad Sci U S A 1997;94:1160- 1165.
30. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000;18:33-37.
31. Jordan M, Schallhorn A, Wurm FM. Transfecting mammalian cells: Optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 1996;24:596-601.
32. Luten J, van Nostrum CF, De Smedt SC, Hennink WE. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J Control Release 2008;126:97-110.
33. Medina-Kauwe LK, Xie J, Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther 2005;12: 1734-1751.
34. Olton DY, Close JM, Sfeir CS, Kumta PN. Intracellular trafficking pathways involved in the gene transfer of nano-structured calcium phosphate-DNA particles. Biomaterials 2011;32:7662-7670.
35. Evans CH, Ghivizzani SC, Robbins PD. Getting arthritis gene therapy into the clinic. Nat Rev Rheumatol 2011; 7:244-249.
36. Lim SH, Liao IC, Leong KW. Nonviral gene delivery from nonwoven fibrous scaffolds fabricated by interfacial complexation of polyelectrolytes. Mol Ther 2006; 13:1163-1172.
37. Chen R, Chiba M, Mori S, Fukumoto M, Kodama T. Periodontal gene transfer by ultrasound and nano/ microbubbles. J Dent Res 2009;88:1008-1013.
38. Passineau MJ, Zourelias L, Machen L, Edwards PC, Benza RL. Ultrasound-assisted non-viral gene transfer to the salivary glands. Gene Ther 2010;17:1318-1324 (erratum 2011;18:424).